Holdings of Stonepine Capital Management, LLC

Name: Holdings of Stonepine Capital Management, LLC
Creator: Titelia
License: https://titelia.com/en/sources

· Original filing · Compare with another fund · Report an error

Net assets: -
Positions: 55 in 3 countries
Top ten: 69.9 % of the equity sleeve
Filed on: Mar 31, 2026

Portfolio shape

Positions

Rank	Company	Shares	Value
1	VERASTEM INC	3,302,300	17.5M $
2	Tenax Therapeutics Inc	975,200	15.6M $
3	Evolus Inc	1,759,091	7.2M $
4	ADMA Biologics Inc	740,000	6.7M $
5	CAMP4 Therapeutics Corp	1,389,622	6.1M $
6	Nektar Therapeutics	85,000	6.1M $
7	Zevra Therapeutics Inc	480,000	4.5M $
8	Corbus Pharmaceuticals Holdings Inc	383,462	3.6M $
9	Abeona Therapeutics Inc	746,587	3.3M $
10	KAZIA THERAPEUTICS LTD	345,179	2.6M $
11	AN2 Therapeutics Inc	713,845	2.4M $
12	XOMA Royalty Corp	69,500	2.2M $
13	Aytu BioPharma Inc	792,289	2.2M $
14	CURIS INC	3,726,406	2M $
15	Tela Bio Inc	2,617,252	1.6M $
16	Inhibikase Therapeutics Inc	957,202	1.6M $
17	Adicet Bio Inc	221,955	1.5M $
18	X4 Pharmaceuticals Inc	335,309	1.4M $
19	Heron Therapeutics Inc	1,402,191	1.1M $
20	Pulmonx Corp	768,288	991.1K $
21	IN8BIO INC	663,412	981.9K $
22	Surrozen Inc	33,005	961.4K $
23	CYTOMX THERAPEUTICS INC	200,000	940K $
24	PMV Pharmaceuticals Inc	708,102	878K $
25	BioAge Labs Inc	50,000	874.5K $
26	MaxCyte Inc	1,004,673	705.8K $
27	Codexis Inc	417,994	681.3K $
28	BOUNDLESS BIO INC	597,682	657.5K $
29	Zentalis Pharmaceuticals Inc	269,100	629.7K $
30	PASITHEA THERAPEUTICS CORP	831,301	616.7K $
31	Phathom Pharmaceuticals Inc	50,010	555.6K $
32	OnKure Therapeutics Inc	132,578	548.9K $
33	Xilio Therapeutics Inc	64,162	539.6K $
34	Verrica Pharmaceuticals Inc	99,735	527.6K $
35	Candel Therapeutics Inc	102,500	502.3K $
36	Precision Optics Corp Inc/Mass	100,000	439K $
37	Upstream Bio Inc	35,000	315K $
38	Opus Genetics Inc	68,688	312.5K $
39	Arvinas Inc	27,500	291.5K $
40	Pliant Therapeutics Inc	224,650	283.1K $
41	Janux Therapeutics Inc	20,000	278K $
42	OmniAb Inc	164,045	257.6K $
43	Xeris Biopharma Holdings Inc	40,030	232.2K $
44	Neumora Therapeutics Inc	100,000	195K $
45	SAB Biotherapeutics Inc	50,000	191.5K $
46	SI-BONE Inc	14,964	189K $
47	CNS PHARMACEUTICALS INC	61,000	145.8K $
48	PROCESSA PHARMACEUTICALS INC	55,000	138.9K $
49	CABALETTA BIO INC	50,000	134.5K $
50	Kalaris Therapeutics Inc	20,400	117.7K $
51	Eledon Pharmaceuticals Inc	35,000	107.8K $
52	Ovid therapeutics Inc	40,000	88.8K $
53	EVAXION A/S	19,713	73.3K $
54	MannKind Corp	16,300	39.9K $
55	BIOATLA INC	65,387	10.5K $

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

Unattributed 100.0 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

United States 97.5 %
Australia 2.5 %
Denmark 0.1 %

Shares are computed on the fund's equities only.

Rank	Country	Lines	Value	Share
1	United States	53	102.1M $	97.48 %
2	Australia	1	2.6M $	2.45 %
3	Denmark	1	73.3K $	0.07 %

Cite this page

Titelia. "Holdings of Stonepine Capital Management, LLC". https://titelia.com/en/funds/US13F1440771